Economic Evaluation of the Randomized Aldactone Evaluation Study (RALES): Treatment of Patients with Severe Heart Failure
dc.contributor.author | Glick, Henry A. | en_US |
dc.contributor.author | Orzol, Sean Michael | en_US |
dc.contributor.author | Tooley, Joseph F. | en_US |
dc.contributor.author | Remme, Willem J. | en_US |
dc.contributor.author | Sasayama, Shigetake | en_US |
dc.contributor.author | Pitt, Bertram | en_US |
dc.date.accessioned | 2006-09-11T14:59:57Z | |
dc.date.available | 2006-09-11T14:59:57Z | |
dc.date.issued | 2002-01 | en_US |
dc.identifier.citation | Glick, Henry A.; Orzol, Sean M.; Tooley, Joseph F.; Remme, Willem J.; Sasayama, Shigetake; Pitt, Bertram; (2002). "Economic Evaluation of the Randomized Aldactone Evaluation Study (RALES): Treatment of Patients with Severe Heart Failure." Cardiovascular Drugs and Therapy 16(1): 53-59. <http://hdl.handle.net/2027.42/44576> | en_US |
dc.identifier.issn | 0920-3206 | en_US |
dc.identifier.issn | 1573-7241 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/44576 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=12085979&dopt=citation | en_US |
dc.description.abstract | Purpose : To use data from the Randomized Aldactone Evaluation Study (RALES) to compare clinical outcomes and costs as part of the assessment of the economic implications of spironolactone treatment of advanced heart failure. | en_US |
dc.format.extent | 100436 bytes | |
dc.format.extent | 3115 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.language.iso | en_US | |
dc.publisher | Kluwer Academic Publishers; Springer Science+Business Media | en_US |
dc.subject.other | Medicine & Public Health | en_US |
dc.subject.other | Cardiology | en_US |
dc.subject.other | Congestive Heart Failure | en_US |
dc.subject.other | Spironolactone | en_US |
dc.subject.other | RALES | en_US |
dc.subject.other | Economics | en_US |
dc.subject.other | Cost-effectiveness | en_US |
dc.title | Economic Evaluation of the Randomized Aldactone Evaluation Study (RALES): Treatment of Patients with Severe Heart Failure | en_US |
dc.type | Article | en_US |
dc.subject.hlbsecondlevel | Biological Chemistry | en_US |
dc.subject.hlbsecondlevel | Chemistry | en_US |
dc.subject.hlbtoplevel | Science | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Division of Cardiology, the, University of Michigan, Ann Arbor, Michigan, USA | en_US |
dc.contributor.affiliationother | Division of General Internal Medicine and the Leonard Davis Institute of Health Economics, the University of Pennsylvania, Philadelphia, PA, 19104, USA | en_US |
dc.contributor.affiliationother | Division of General Internal Medicine and the Leonard Davis Institute of Health Economics, the University of Pennsylvania, Philadelphia, PA, 19104, USA | en_US |
dc.contributor.affiliationother | Pharmacia, Skokie, IL, USA | en_US |
dc.contributor.affiliationother | STICARES Cardiovascular Research Foundation, RHOON, The Netherlands | en_US |
dc.contributor.affiliationother | Kyoto University, Kyoto, Japan | en_US |
dc.contributor.affiliationumcampus | Ann Arbor | en_US |
dc.identifier.pmid | 12085979 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/44576/1/10557_2004_Article_405789.pdf | en_US |
dc.identifier.doi | http://dx.doi.org/10.1023/A:1015371616135 | en_US |
dc.identifier.source | Cardiovascular Drugs and Therapy | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.